Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
Clinical trial NCT00210626 · TERMINATED
Trial details
- NCT number
- NCT00210626
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2008-06-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.